Pilot Study of Positive Affect Training for Endocrine Therapy Medication Adherence

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to pilot and refine an online behavioral intervention based on Positive Affect Training (PAT) that aims to increase positive emotional attitudes and decrease negative emotional attitudes toward endocrine therapy (ET, i.e., anti-hormonal medication) and to increase positive affect and decrease negative affect more generally, among post-treatment breast cancer survivors who are prescribed ET to prevent recurrence of breast cancer.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 21
Healthy Volunteers: f
View:

• hormone receptor-positive breast cancer stages 0-3

• have finished primary treatment (chemotherapy/radiation/surgery)

• are prescribed endocrine therapy (ET) currently or within the last two years

• score above specified cut off (range, 0-10) on any of three questions:

‣ How upset are you by having to take anti-hormonal therapy

⁃ How bothered are you by the side effects?

⁃ How difficult is it for you to take your anti-hormonal medication every day?

• have internet access to complete online assessments and intervention components or agree to use and return a study wifi-activated iPad.

Locations
United States
Colorado
University of Colorado Boulder
RECRUITING
Boulder
Contact Information
Primary
Madeline Nealis, MPH
archlab@colorado.edu
720-897-1850
Backup
Sienna Russell
archlab@colorado.edu
720-897-1850
Time Frame
Start Date: 2024-03-12
Estimated Completion Date: 2024-12-12
Participants
Target number of participants: 40
Treatments
Experimental: Online Program
Online program
Related Therapeutic Areas
Sponsors
Leads: Joanna Arch

This content was sourced from clinicaltrials.gov